{"id":46352,"date":"2022-07-19T23:01:55","date_gmt":"2022-07-19T21:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/"},"modified":"2022-07-19T23:01:55","modified_gmt":"2022-07-19T21:01:55","slug":"electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/","title":{"rendered":"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference"},"content":{"rendered":"
\n

NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (\u201cElectromed\u201d or the \u201cCompany\u201d) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate in the Canaccord Genuity 42nd Annual Growth Conference on August 8-11, 2022. Management will be available for investor one-on-ones on Wednesday, August 10, 2022.\n<\/p>\n

\nAbout Electromed, Inc.<\/b>\n<\/p>\n

\nElectromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest\u00ae Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about the Company can be found at www.smartvest.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMichelle Wirtz, Interim Chief Financial Officer
\n
(952) 758-9299
\n
investorrelations@electromed.com<\/a><\/p>\n

Mike Cavanaugh, Investor Relations
\n
ICR Westwicke
\n
(617) 877-9641
\n
mike.cavanaugh@westwicke.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (\u201cElectromed\u201d or the \u201cCompany\u201d) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate in the Canaccord Genuity 42nd Annual Growth Conference on August 8-11, 2022. Management will be … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46352","6":"format-standard","7":"category-industry"},"yoast_head":"\nElectromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (\u201cElectromed\u201d or the \u201cCompany\u201d) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate in the Canaccord Genuity 42nd Annual Growth Conference on August 8-11, 2022. Management will be ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-19T21:01:55+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference\",\"datePublished\":\"2022-07-19T21:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\\\/\"},\"wordCount\":149,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\\\/\",\"name\":\"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-07-19T21:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend","og_description":"NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (\u201cElectromed\u201d or the \u201cCompany\u201d) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate in the Canaccord Genuity 42nd Annual Growth Conference on August 8-11, 2022. Management will be ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-19T21:01:55+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference","datePublished":"2022-07-19T21:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/"},"wordCount":149,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/","url":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/","name":"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-07-19T21:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-to-participate-in-the-canaccord-genuity-42nd-annual-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46352"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46352\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}